Literature DB >> 24959472

Recurrent severe anaemia: a rare presentation of parvovirus b19 infection.

Santokh Singh1, Gian Chand2, Shiv Charan3, Sahil Arora4, Parampreet Singh5.   

Abstract

Secondary pure red cell aplasia is usually seen in immunocompromised hosts or patients who have chronic haemolytic anaemia, which is caused by blood transfusion related transmission. The present patient, a 30-year-old immunocompetent female, presented several times with recurrent severe anaemia, over a period of one and half years. Her history, clinical examination and investigations did not reveal any indigenous drug intake, previous blood transfusions, haemolytic disorders, myeloproliferative disorders, pregnancies, autoimmune diseases or thymoma. She was found to have a thalassaemia minor trait, on the basis of which severity and recurrence of anaemia could not be explained, and on further evaluation, she was diagnosed to have acute aplastic crisis caused by Parvovirus B19 induced, acquired pure red cell aplasia. The co- existence of these two haematological disorders in an immunocompetent, non-transfusion dependent individual is rare, which makes our case report unique.

Entities:  

Keywords:  Beta thalassemia minor trait; Immunocompetent individual; Non transfusion dependent; Secondary pure red cell aplasia

Year:  2014        PMID: 24959472      PMCID: PMC4064854          DOI: 10.7860/JCDR/2014/7840.4250

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.

Authors:  T W Crook; B B Rogers; R D McFarland; S H Kroft; P Muretto; J A Hernandez; M J Latimer; R W McKenna
Journal:  Hum Pathol       Date:  2000-02       Impact factor: 3.466

Review 3.  Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.

Authors:  Yoann Crabol; Benjamin Terrier; Flore Rozenberg; Vincent Pestre; Christophe Legendre; Olivier Hermine; Catherine Montagnier-Petrissans; Loïc Guillevin; Luc Mouthon
Journal:  Clin Infect Dis       Date:  2012-12-12       Impact factor: 9.079

Review 4.  Pure red-cell aplasia "epidemic"--mystery completely revealed?

Authors:  Francesco Locatelli; Lucia Del Vecchio; Pietro Pozzoni
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

Review 5.  Pure red cell aplasia of pregnancy: a distinct clinical entity.

Authors:  R I Baker; A Manoharan; E de Luca; C G Begley
Journal:  Br J Haematol       Date:  1993-11       Impact factor: 6.998

Review 6.  Pure red cell aplasia secondary to treatment with erythropoietin.

Authors:  Francesco Locatelli; Lucia Del Vecchio
Journal:  J Nephrol       Date:  2003 Jul-Aug       Impact factor: 3.902

Review 7.  Acquired pure red cell aplasia: updated review of treatment.

Authors:  Kenichi Sawada; Naohito Fujishima; Makoto Hirokawa
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998

  7 in total
  2 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis.

Authors:  Kumaran Vadivel; Ramamurthy Mageshbabu; Sathish Sankar; Amita Jain; Vivekanandan Perumal; Padma Srikanth; Ghosh Asit Ranjan; Aravindan Nair; Eric A F Simoes; Balaji Nandagopal; Gopalan Sridharan
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.